Trial intelligence / Profile preview

WALANT with tranexamic acid versus epinephrine for carpal tunnel release

RBR-2njtg49Phase 4Completed

Sponsor
Hospital de Caridade São Vicente de Paulo
Start
Dec 2022
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of tranexamic acid, epinephrine, lidocaine, sodium bicarbonate and saline in carpal tunnel syndrome (CTS) (2 arms), sponsored by Hospital de Caridade São Vicente de Paulo. Started Dec 2022; status: completed.

02

Drugs

tranexamic acidepinephrinelidocainesodium bicarbonatesaline
03

Conditions

carpal tunnel syndrome (CTS)

Beyond the preview

Go deeper on RBR-2njtg49.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-2njtg49.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call